Thomas Malley Bei Gene, Ltd. (BGNE) insider trading activity

BGNE Quotes by TradingView

Thomas Malley is Director of BeiGene, Ltd.. Currently has a direct ownership of 46,696 shares of BGNE, which is worth approximately $9.26 Million. The most recent transaction as insider was on Jun 15, 2023, when has been sold 12,922 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.7K
0% 3M change
0% 12M change
Total Value Held $9.26 Million

Thomas Malley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 15 2023
BUY
Grant, award, or other acquisition
-
12,922 Added 21.67%
46,696 Ordinary Shares
Jun 22 2022
BUY
Grant, award, or other acquisition
-
16,692 Added 33.08%
33,774 Ordinary Shares
Jun 16 2021
BUY
Grant, award, or other acquisition
-
7,800 Added 31.35%
17,082 Ordinary Shares

Also insider at

KURA
Kura Oncology, Inc. Healthcare
KNSA
Kiniksa Pharmaceuticals, Ltd. Healthcare
TM

Thomas Malley

Director
Camana Bay, Grand Cayman, E9

Track Institutional and Insider Activities on BGNE

Follow BeiGene, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BGNE shares.

Notify only if

Insider Trading

Get notified when an Bei Gene, Ltd. insider buys or sells BGNE shares.

Notify only if

News

Receive news related to BeiGene, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BGNE